
Terri Bailey Pustilnik MD
Gynecologic Oncology
Gynecologic Oncologists at Texas Oncology-Deke Slayton Cancer Center
Join to View Full Profile
501 W Medical Center BlvdWebster, TX 77598
Phone+1 281-332-7505
Fax+1 281-332-7616
Dr. Pustilnik is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- I am a board certified gynecological oncologist. I had offices in the medical center and Nasa area. I have a special interest in minimally invasive surgery and have performed over 6000 robotic surgeries in women with cancer, BMI over 70, 3000 gm fibroid uterus, as well as single site robotic surgery. I also have a special interest in finding out why someone has cancer and what they can do to improve their health.
Education & Training
University of Texas M D Anderson Cancer CenterFellowship, Gynecologic Oncology, 1999
Yale-New Haven Medical CenterResidency, Obstetrics and Gynecology, 1992 - 1996
Washington University in St. Louis School of MedicineClass of 1992
Certifications & Licensure
TX State Medical License 1997 - 2028
AL State Medical License 1999 - 2001
PA State Medical License 1996 - 2000
American Board of Obstetrics and Gynecology Obstetrics & Gynecology
American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014-2020
- CMS Meaningful Use Stage 2 Certification iKnowMed EHR, McKesson, 2013-2017
- CMS Meaningful Use Stage 1 Certification iKnowMed EHR, McKesson, 2013-2017
Publications & Presentations
PubMed
- 51 citationsWHAT WOMEN WITH OVARIAN CANCER THINK AND KNOW ABOUT GENETIC TESTINGRobin A. Lacour, Molly S. Daniels, Shannon N. Westin, Larissa A. Meyer, Catherine Burke
Gynecologic Oncology. 2008-10-01 - 27 citationsLysophosphatidic acid induction of urokinase plasminogen activator secretion requires activation of the p38MAPK pathwayVeronica C. Estrella, Astrid Eder, Shuying Liu, Terri B. Pustilnik, Fazal H. Tabassam
International Journal of Oncology. 2007-08-01 - 200 citationsLysophospholipid growth factors in the initiation, progression, metastases, and management of ovarian cancer.Xianjun Fang, Douglas C. Gaudette, Tatsuro Furui, Muling Mao, Veronica C. Estrella
Annals of the New York Academy of Sciences. 2006-01-25
Press Mentions
Terri Pustilnik, M.D.: Preventing Cervical CancerJanuary 10th, 2019
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









